Correlation Between C4 Therapeutics and Seer
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Seer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Seer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Seer Inc, you can compare the effects of market volatilities on C4 Therapeutics and Seer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Seer. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Seer.
Diversification Opportunities for C4 Therapeutics and Seer
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CCCC and Seer is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Seer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seer Inc and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Seer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seer Inc has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Seer go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Seer
Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Seer. In addition to that, C4 Therapeutics is 1.95 times more volatile than Seer Inc. It trades about -0.06 of its total potential returns per unit of risk. Seer Inc is currently generating about 0.11 per unit of volatility. If you would invest 177.00 in Seer Inc on November 3, 2024 and sell it today you would earn a total of 62.00 from holding Seer Inc or generate 35.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
C4 Therapeutics vs. Seer Inc
Performance |
Timeline |
C4 Therapeutics |
Seer Inc |
C4 Therapeutics and Seer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with C4 Therapeutics and Seer
The main advantage of trading using opposite C4 Therapeutics and Seer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Seer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seer will offset losses from the drop in Seer's long position.C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Directory Find actively traded commodities issued by global exchanges |